Price movement over the last 24 hours
Agilent Technologies Inc vs NextEra Energy, Inc. — how do they compare? Agilent Technologies Inc trades at $128.38 (market cap $37.04B), while NextEra Energy, Inc. trades at $88.22 (market cap $184.51B). The key difference: NextEra Energy, Inc. is far larger — about 5× Agilent Technologies Inc's market cap, and NextEra Energy, Inc. pays the higher dividend (2.82%). Which is the better fit depends on your goals.
| A | NEE | |
|---|---|---|
Market Cap | $37.04B | $184.51B |
Sector | Health | Utilities |
52-Week High | $157.20 | $97.88 |
52-Week Low | $110.24 | $69.77 |
Enterprise Value | $38.59B | $286.92B |
Dividend Yield | 0.78% | 2.82% |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
NextEra Energy (NEE) trades at $88.47, up 0.15% today, with a neutral technical outlook and strong analyst support. The stock shows solid fundamentals with a P/E of 22.19, net income margin of 29.37%, and recent earnings beats in Q1 2026. Revenue grew to $27.41B in 2025, though net income dipped slightly to $6.84B. A recent $0.62 dividend underscores shareholder returns, while the Dominion Energy merger positions NEE for AI-driven power demand growth.
Outlook remains positive with a consensus price target of $104.29 (18% upside), driven by clean energy demand and partnerships. Risks include rising debt-to-asset ratios (47.6% in 2025) and regulatory pressures. Institutional sentiment is bullish with 66.7% buy ratings, but investors should monitor execution on capital expenditures and interest rate sensitivity.
Trailing returns across standard periods
Latest headlines on both assets
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.
Read more on NEE →